FDA Votes To Keep Black Box Warning On Pfizer Anti-smoking Drug

October 16, 2014 8:50 PM

6 0

FDA Votes To Keep Black Box Warning On Pfizer Anti-smoking Drug

(Reuters) - Pfizer Inc failed in its attempt to remove a black box warning from its controversial quit-smoking drug, Chantix, after an advisory panel to the U.S. Food and Drug Administration voted against the removal.

A majority of the panel voted to keep the health regulator's most severe warning label on the treatment, in keeping with the recommendations of FDA staff two days earlier.

Read more

To category page

Loading...